Spiro azetidine isoxazole derivatives and their use as SSTR antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9605000
APP PUB NO 20160060273A1
SERIAL NO

14775265

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITEDOSAKA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hirose, Hideki Fujisawa, JP 22 153
Kasai, Shizuo Fujisawa, JP 17 182
Kina, Asato Fujisawa, JP 12 38
Mizojiri, Ryo Fujisawa, JP 12 76
Morimoto, Sachie Fujisawa, JP 4 10
Nakahata, Takashi Fujisawa, JP 8 12
Ogino, Masaki Fujisawa, JP 42 450
Takakura, Nobuyuki Fujisawa, JP 25 165
Yamasaki, Takeshi Fujisawa, JP 86 673
Yamashita, Tohru Fujisawa, JP 24 220

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00